Inventor · Sharon, MA, US

Brian M. Andresen

25Patents
7h-index
105Co-inventors
72Inventor score

Filing activity: Apr 9, 1999 → Jun 18, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8551984B2 Aminopyrimidines as SYK inhibitors Chemistry; Metallurgy 22 Active
US8796310B2 Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors Chemistry; Metallurgy 15 Active
US9487490B2 3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof Emerging Cross-Sectional Technologies 15 Active
US9663502B2 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 12 Active
US9783511B2 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 9 Active
US9809561B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 8 Active
US10766919B2 Cyclic di-nucleotide compounds as sting agonists Human Necessities 7 Active
US10221146B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 6 Active
US10738074B2 Cyclic di-nucleotide compounds as STING agonists Human Necessities 5 Active
US10759825B2 Cyclic di-nucleotide compounds as STING agonists Human Necessities 5 Active
US10513525B2 Methods and compositions for studying, imaging, and treating pain Chemistry; Metallurgy 4 Active
US9943516B2 Inhibitors of IRAK4 activity Chemistry; Metallurgy 4 Active
US9174999B2 Methods and compositions for studying, imaging, and treating pain Chemistry; Metallurgy 4 Active
US9969749B2 Inhibitors of IRAK4 activity Chemistry; Metallurgy 4 Active
US6114568A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors Emerging Cross-Sectional Technologies 2 Expired
US11453697B1 Cyclic di-nucleotide compounds as sting agonists Human Necessities 1 Active
US10246457B2 Indazole and azaindazole Btk inhibitors Chemistry; Metallurgy 1 Active
US11685761B2 Cyclic di-nucleotide compounds as sting agonists Chemistry; Metallurgy 0 Active
US6624313B2 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists Chemistry; Metallurgy 0 Expired
US10208047B2 Tertiary alcohol imidazopyrazine BTK inhibitors Human Necessities 0 Active
US9085536B2 Aconitine compounds, compositions, uses, and preparation thereof Human Necessities 0 Active
US9598405B2 Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors Human Necessities 0 Active
US10745364B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 0 Active
US9745295B2 Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors Chemistry; Metallurgy 0 Active
US9822107B2 Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.